Vascular complications and gene therapy

Author： Roy Sayon   Rothschild Jennifer G   Chen Amy  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.3, Iss.1, 2003-02, pp. : 71-83

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vascular-targeted cancer gene therapy

By Dougherty Graeme J   Davis Peter D   Dougherty Shona T  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 12, 2004-12 ,pp. : 1911-1920

Informa Healthcare

Access to resources Recommend Favorite

Improved Expression of Vascular Endothelial Growth Factor by Naked DNA in Mouse Skeletal Muscles: Implication for Gene Therapy of Ischemic Diseases

By Lee Y.   Park E.J.   Yu S.S.   Kim D-K.   Kim S.  

Biochemical and Biophysical Research Communications, Vol. 272, Iss. 1, 2000-05 ,pp. : 230-235

Elsevier

Access to resources Recommend Favorite

Gene therapy of metachromatic leukodystrophy

By Matzner Ulrich   Gieselmann Volkmar  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 1, 2005-01 ,pp. : 55-65

Informa Healthcare

Access to resources Recommend Favorite

RNAi as a gene therapy approach

By Caplen Natasha J  

Expert Opinion on Biological Therapy, Vol. 3, Iss. 4, 2003-07 ,pp. : 575-586

Informa Healthcare

Access to resources Recommend Favorite

Restenosis and gene therapy

By Quarck R.   Holvoet P.  

Expert Opinion on Biological Therapy, Vol. 1, Iss. 1, 2001-01 ,pp. : 79-91

Informa Healthcare

Access to resources Recommend Favorite